Health Sciences Acquisitions Corp Human Resources Contracts & Agreements
19 Contracts & Agreements
- Bonus & Incentive Agreements (3 contracts)
- Consulting Agreements (1)
- Employment Agreements (13)
- Separation Agreements (2)
- Employment Agreement with (Filed With SEC on November 7, 2024)
- Employment Agreement with Michael Geffner, dated as of January 9, 2024 (Filed With SEC on February 12, 2024)
- Employment Agreement with Jay Stout, dated as of April 11, 2023 (Filed With SEC on May 22, 2023)
- UK Sub-Plan to the Immunovant, Inc. 2019 Equity Incentive Plan (Filed With SEC on February 3, 2023)
- Employment Agreement with Mark Levine, dated as of January 19, 2022 (Filed With SEC on June 8, 2022)
- Employment Agreement with (Filed With SEC on February 4, 2022)
- Employment Agreement with Renee Barnett, dated as of September 14, 2021 (Filed With SEC on September 15, 2021)
- Consulting Agreement between Immunovant, Inc. and Pamela Yanchik Connealy, dated July 13, 2021 (Filed With SEC on July 13, 2021)
- Employment Agreement with Rita Jain, dated as of December 23 (Filed With SEC on June 1, 2021)
- Separation Agreement and General Release, dated November 13, 2020, by and between W. Bradford Middlekauff (Filed With SEC on February 16, 2021)
- Employment Agreement with Michael J. Elliott, dated as of August 24, 2020 (Filed With SEC on August 31, 2020)
- Separation Agreement and General Release, dated April 7, 2020, by and between Robert K. Zeldin and Immunovant, Inc (Filed With SEC on April 8, 2020)
- Employment Agreement with Robert K. Zeldin, dated as of July 8, 2019, as amended July 21, 2019 (Filed With SEC on December 20, 2019)
- Employment Agreement with W. Bradford Middlekauff, dated as of April 15, 2019 (Filed With SEC on December 20, 2019)
- Employment Agreement with Julia G. Butchko, dated as of October 9, 2019 (Filed With SEC on December 20, 2019)
- Employment Agreement with Pamela Connealy, dated as of October 22, 2019, as amended November 20, 2019 (Filed With SEC on December 20, 2019)
- Employment Agreement with Peter Salzmann, dated as of May 30, 2019 (Filed With SEC on December 20, 2019)
- 2018 Equity Incentive Plan of Immunovant Sciences Ltd., and forms of award agreements thereunder (Filed With SEC on December 20, 2019)
- 2019 Equity Incentive Plan of Immunovant, Inc. and forms of award agreements thereunder (Filed With SEC on December 20, 2019)
